Latest data from September 24, 2021
Number of Health Center respondents = 18 (69% of all Health Centers)
Data represents information provided by health centers from a single, specified reporting date. Summary information across report dates is not comparable due to differences in which health centers responded for a given report date.
Patients Tested
| Metrics | Value |
|---|---|
| Patients Tested for COVID-19, Virus Detection (PCR, antigen)1 | 5,567 |
| Racial and/or Ethnic Minority Patients Tested for COVID-19, Virus Detection (PCR, antigen) | 43.33% |
| Patients Tested Positive for COVID-19, Virus Detection (PCR, antigen)1 | 655 |
| Racial and/or Ethnic Minority Patients Tested Positive for COVID-19, Virus Detection (PCR, antigen) | 32.10% |
Patients by Race and Ethnicity
| Race/Ethnicity | Patients Tested, Virus Detection (PCR, antigen)2 | Patients Tested Positive, Virus Detection (PCR, antigen)2 |
|---|---|---|
| White, Non-Hispanic/Latino Patients | 53.19% | 64.58% |
| White, Hispanic/Latino Patients | 11.17% | 6.41% |
| Black/African American, Non-Hispanic/Latino Patients | 20.57% | 17.71% |
| Black/African American, Hispanic/Latino Patients | 0.49% | 0.61% |
| Asian Patients3 | 1.15% | 0.61% |
| American Indian/Alaska Native Patients3 | 0.52% | 0.31% |
| Native Hawaiian/Other Pacific Islander Patients3 | 0.36% | 0.00% |
| Patients with More than one race3 | 1.13% | 0.61% |
| Hispanic/Latino Ethnicity Patients (Unreported/Refused to report race) | 5.28% | 4.27% |
| Non-Hispanic/Latino Ethnicity Patients (Unreported/Refused to report race) | 1.02% | 1.37% |
| Unreported/Refused to Report Race and Ethnicity | 5.12% | 3.51% |
Patients Vaccinated
| Metrics | Value |
|---|---|
| COVID-19 Immunization Series Initiated | 942 |
| Racial and/or Ethnic Minority Patients Who Initiated COVID-19 Immunization | 64.31% |
| COVID-19 Immunization Series Completed | 1,143 |
| Racial and/or Ethnic Minority Patients Who Completed COVID-19 Immunization | 70.30% |
| COVID-19 Immunization Series Additional | 174 |
| Racial and/or Ethnic Minority Patients Who Received an Additional Dose of COVID-19 Vaccine | 45.96% |
Vaccinations by Race and Ethnicity
| Race/Ethnicity | Patient COVID-19 Immunization Series Initiated2 | Patient COVID-19 Immunization Series Completed2 | Patient COVID-19 Immunization Series Additional2 |
|---|---|---|---|
| White, Non-Hispanic/Latino Patients | 32.17% | 27.21% | 50.00% |
| White, Hispanic/Latino Patients | 23.14% | 24.15% | 13.22% |
| Black/African American, Non-Hispanic/Latino Patients | 24.52% | 26.07% | 12.07% |
| Black/African American, Hispanic/Latino Patients | 0.42% | 0.17% | 0.57% |
| Asian Patients3 | 1.38% | 0.61% | 5.17% |
| American Indian/Alaska Native Patients3 | 0.32% | 1.14% | 8.62% |
| Native Hawaiian/Other Pacific Islander Patients3 | 0.21% | 0.52% | 0.00% |
| Patients with More than one race3 | 0.42% | 0.52% | 0.57% |
| Hispanic/Latino Ethnicity Patients (Unreported/Refused to report race) | 7.54% | 11.20% | 2.30% |
| Non-Hispanic/Latino Ethnicity Patients (Unreported/Refused to report race) | 1.70% | 1.14% | 4.02% |
| Unreported/Refused to Report Race and Ethnicity | 8.17% | 7.26% | 3.45% |
Testing Logistics
Average Turnaround Time for COVID-19 Test Results, Virus Detection (PCR, antigen)
| Metrics | Value |
|---|---|
| Less Than 1 Hour | 22.22% |
| 1 to 24 Hours | 33.33% |
| More Than 24 Hours | 44.44% |
| N/A | 0.00% |
Vaccine Logistics
Challenges in Deploying the COVID Vaccine
| Metrics | Value |
|---|---|
| Financial reimbursement for costs associated with vaccine administration | 5.56% |
| Staffing to administer the vaccine | 16.67% |
| Vaccine confidence | 38.89% |
| Vaccine storage capacity | 0.00% |
| Vaccine supply | 0.00% |
| Other | 22.22% |
| None | 33.33% |
Operations and Staff
| Metrics | Value |
|---|---|
| Health Center Weekly Visits Compared to Pre-COVID 19 Weekly Visits | 89.72% |
| Average Percent of Health Center Visits Conducted Virtually | 13.61% |
Mobile Vans, Pop-Up Clinics, and School-Based Sites
| Metrics | Value |
|---|---|
| Percent of Health Centers Hosting Mobile Vans, Pop-Up, and/or School-Based Clinics | 44.44% |
| Number of Mobile Van Sites | 22 |
| Number of Pop-up Clinics | 12 |
| Number of School-Based Vaccination Sites | 2 |
Monoclonal Antibody Therapy
Methods in Providing Access to Monoclonal Antibody Therapy
| Metrics | Value |
|---|---|
| Direct provision of monoclonal antibody therapies | 0.00% |
| Refer patients to another organization that provides monoclonal antibody therapies | 33.33% |
| None | 66.67% |
Challenges in Providing Access to Monoclonal Antibody Therapy
| Metrics | Value |
|---|---|
| Access to therapeutics | 16.67% |
| Patient awareness/education | 0.00% |
| Staffing capacity | 22.22% |
| Therapy administration/onsite logistics | 22.22% |
| Other | 16.67% |
| None | 33.33% |
1 The reported number of patients tested do not represent the same patients included in the reported number of patients tested positive due to a lag between the date the specimen is collected and the availability of test results. Positivity rates cannot be inferred by dividing patients tested positive by patients tested for this reason.
2 Percentages may not add to 100% due to rounding to the hundredths.
3 Includes Hispanic/Latino and Non-Hispanic/Latino.
